Todd R. Daviau, Ph.D., MBA

President and CEO

Todd Daviau, an accomplished scientific leader, brings almost 30 years of pharmaceutical experience and knowledge to CoreRx, as well as being one of principal founders.

Prior to founding CoreRx, he served as Director of the Analytical and Pre-Formulation Laboratory for MDS Pharma Services in Tampa, FL. In this role, he directed the analytical group of over 20 scientists responsible for all the analytical, stability, and pre-formulation activities in support of over 75 stability, formulation and/or manufacturing projects.

Dr. Daviau was also a strategic analytical team member with Nova Pharmaceuticals (later Guilford Pharmaceuticals), and involved in a number of NDA programs, including the development of Gliadel®.

Todd is acknowledged as a creative leader focused on advancing projects with experience in multiple therapeutic areas. He is an expert in optimizing the drug discovery process through optimal resource allocation, process improvements and using scientific acumen to resolve complex project related issues. Todd brings a breadth of pharmaceutical experience, from drug discovery through research and development, analytical (R&D and QC.) and management experience in top-tier multinational pharmaceutical organizations. He is recognized as global, strategic thinker, with demonstrated ability to deliver pre-clinical and clinical candidates, within stringent timelines.

Dr. Daviau holds a bachelor’s degree in Marine Biology and Chemistry, a PhD in Natural Product Chemistry and an MBA in Business Management.

Bill Reid

Executive Director and Chief Operating Officer

Bill Reid began his career as a quality control chemist at R.P. Scherer and then moved on as an analytical chemist to Bausch & Lomb developing methods to characterize nasal products.  His work there played a critical role with in-vitro bioequivalence studies which resulted in some of the first ANDA approvals for nasal products. Bill moved on from there to join MDS Pharma Services where he initially served an analytical chemist with a focus on characterization testing across a number dosage forms. He later moved into project management, where he established a strong track record of consistently delivering on projects with significant challenges and tight time lines. His proven team leadership and attention to detail resulted in great customer feedback.

Bill holds a B.S. degree in Chemistry from Delaware Valley College in Doylestown, PA.


Bob Berg

Chief Financial Officer

Mr. Berg is a highly accomplished CFO with over 35 years of experience in all areas of business and personnel management with private and public companies.

Prior to joining CoreRx, Bob served in various executive roles with companies including West-Ward Pharmaceuticals, Boehringer Ingelheim, and the Siemon Company. He has also been a guest teacher and speaker for healthcare economics at the Miami University (Oxford Ohio).

Mr. Berg holds an MBA in Business Administration and Finance from the University of New Haven, and a Bachelor of Arts, Economics and Business Studies from Assumption College.

Mark DaFonseca

Chief Business Officer

Mark DaFonseca brings nearly 20 years of pharmaceutical and business development experience across the CRO/CMO sector.

Prior to CoreRx he began his career with AAI International as an analytical chemist, followed by positions of increasing responsibility in client services and business development. From there, Mark focused on sales & marketing, successfully leading business development teams with Aptuit, Catalent, and CRMG prior to joining CoreRx. This background has provided him exposure acoss the entire drug development paradigm, including experience in discovery, preclinical, CMC and clinical trial activities.

Mark holds both a MBA in Business and a B.S. in Biology from the University of North Carolina, Wilmington.

Mohammed S. Shekhani, PhD

Vice President of Quality 

Mohammed Shekhani is an accomplished professional with over 20 years of expertise in the Pharmaceutical/Biotechnology industry.

Prior to CoreRx, he served as a Senior Director of Quality Assurance and Principal Investigator for PII, Pharmaceuticals International, Inc. He also held other executive roles with Madison Molecular Research and Centrose Pharmaceuticals. Mohammed’s expertise in a variety of areas including regulatory compliance, quality systems, quality strategies, quality risk management, document control, corrective and preventative actions, discrepancy and failure investigations.  He has an extensive background in validation, technology transfer and R&D, and in-depth scientific and technical knowledge of analytical and Organic Chemistry.

Dr. Shekhani holds a Doctorate in organic chemistry from the SUNY- Stony Brook.

Janice Cacace, Ph.D.

Senior Director of Formulation Development

Dr. Janice Cacace’s career has spanned over 30 years in the pharmaceutical industry in the areas of formulation, product development, consulting and academia.

She has held management level positions involved in pharmaceutical product development for 15 years, at Sancilio and Company, Azopharma and Ivax. Her experience covers a wide range of dosage forms and product types. These include tablets, capsules, spray-dried dispersions, wet and dry granulations, soft gelatin capsules, oral liquids, topicals, injectables, medical foods, and covers both generic and new chemical entities.

Dr. Cacace holds a Bachelor of Science Degree in Pharmacy from Purdue University, and a Doctor of Philosophy in Pharmaceutics from the University of Florida.

Simon Daw

Executive Director of Technical Operations

Simon Daw brings nearly 30 years of manufacturing experience across the pharmaceutical industry, with extensive GMP operations knowledge and a proven track record of leadership. Prior to joining CoreRx, he held various management level manufacturing positions at DSM, Lanett Company, Solvay Pharmaceuticals, Bausch and Lomb, Novapharm, and GlaxoSmithKline aimed at delivering cost-effective improvements and implementing needed systems and operational changes in both the Clinical and Commercial manufacturing setting. Simon’s proven ability to implement new technologies and processes in high performing teams is a key asset for his role with CoreRx. Simon holds a B.S. in Electrical Engineering from the University of Bath, England.

Eric Primelles-Perez

Director of Analytical

Eric Primelles-Perez has held management level positions in analytical development of pharmaceutical products for nearly a decade at Wyeth, Pfizer and Nephron Pharmaceuticals. His experience covers a wide range of dosage forms and product types and includes:  tablets, capsules, soft gelatin capsules, oral liquids, inhalation solutions and suspensions, ophthalmic, injectables, dietary supplements, nutritionals, and covers both generic and new chemical entities.

 Eric holds a Bachelor of Science Degree in Chemistry from University of Las Villas, Cuba. He attended the Doctoral Program in Science (Chemistry), University of Las Villas, Cuba.

Partner with us

When you’re ready to get expertise, flexibility, and reliability with your pharmaceutical formulation project, call us or fill out this form. We’ll be happy to answer your questions, provide a tour of our facilities, and get your project started today.